Skip to main content
Press Releases
-
(Press Release)
NMS Labs to Expand Operations with New Horsham, Penn. Facility
-
(Press Release)
Novel Designer Opioids Evade Detection at Most Labs, But Not at NMS
-
(Press Release)
NMS Labs Announces Toxicological Confirmation of Hundreds of Deaths Involving Novel Designer Opioids in the United States
-
(Press Release)
NMS Labs Proudly Welcomes Dr. Marilyn Huestis as Senior Scientific Advisor
-
(Press Release)
NMS Labs and SmallPond Announce Commitment to Join Forces in Delivering Total Property Crimes Testing and Local DNA Databasing Solution for Law Enforcement
-
(Press Release)
The Importance of Basing Marijuana Impaired Driving Laws on Sound Science
-
(Press Release)
NMS Labs Testing Helps to Enforce DEA Control of Synthetic Marijuana
-
(Press Release)
NMS Labs Earns Prestigious International Accreditation from the American Society of Crime Laboratory Directors/Laboratory Accreditation Board (ASCLD/LAB)
-
(Press Release)
NMS Labs Reports Updated Synthetic Cannabinoids Panel Leads to Higher Positivity Rates
-
(Press Release)
NMS Labs Hosts a Webinar Highlighting the New Flakka Trend
-
(Press Release)
NMS Labs Recognizes an Increase in Heroin and Fentanyl Use
-
(Press Release)
NMS Labs and StopDUID.org Sponsor Update of 50 States DUI Law Compilation
-
(Press Release)
NMS Labs Selects RapidHIT® Platform to Deliver DNA Results in Record Time
-
(Press Release)
New Article highlights a more Effective Method for Analyzing Sexual Assault Evidence
-
(Press Release)
NMS Labs Announces Crucial New Tool for Impaired Driving Investigation
-
(Press Release)
NMS Labs Dr. Barry Logan Appointed to NIST Forensic Science Standards Board
-
(Press Release)
NMS Labs Launches Testing Solution to Detect Pyrrolidinophenones, a New Group of Designer Drugs
-
(Press Release)
NMS Labs Welcomes Jack Wright as Vice President of Sales and Marketing
-
(Press Release)
Robin Freeman is named the New General Manager of IFL
-
(Press Release)
NMS Labs Launches Testing Solution to Detect NBOMes, a Deadly Next Generation Designer Drug
-
(Press Release)
New Publication Highlights the Human Health Risks and Impairing Effects of Synthetic Cannabinoid Drugs
-
(Press Release)
NMS Labs Announces its Highly Specific Plasma Catecholamines Test by 2D-LC-MS/MS
-
(Press Release)
NMS Labs Statement on Yohe Decision – Right to Confrontation
-
(Press Release)
NMS Labs Appoints Pierre Cassigneul Chief Executive Officer
-
(Press Release)
NMS Labs Offers Genotype tests for Tramadol, Oxycodone and Codeine
-
(Press Release)
Cold Murder Case solutions group recognizes Dr. Rieders for decades of service to Vidocq Society and Forensic Science
-
(Press Release)
Dr. Barry Logan of NMS Labs Receives Prestigious International Award for Traffic Safety Research
-
(Press Release)
NMS Labs releases most recent designer drug trending data: 38% positivity rate reflects presence of emerging “Bath Salts”
-
(Press Release)
NMS Labs offers testing for acetyl fentanyl in response to CDC Health Advisory
-
(Press Release)
DesignerDrugTrends.org fills information void as nation’s first centralized resource for legislators, law enforcement and the medical community
-
(Press Release)
AAFS Recognizes Award-Winning Forensic Toxicologists of NMS Labs
-
(Press Release)
NMS Labs Proudly Welcomes Dr. Wenzhe Li as Senior Director of Clinical Services
-
(Press Release)
NMS Labs Announces Types and Amounts of Chemicals Used in Synthetic Marijuana Products Varies Widely, as Does Impact on Users
-
(Press Release)
NMS Labs launches highly comprehensive "bath salts" and designer stimulants testing to mirror designer drug trends on the street
-
(Press Release)
Clandestine Chemists Diversify to Stay Ahead of Latest Round of Drug Scheduling
-
(Press Release)
Pioneer of Postmortem Toxicology Joins NMS Labs
-
(Press Release)
NMS Labs launches updated legal blood alcohol test with Statement of Certainty™
-
(Press Release)
New Synthetic Drugs Circumvent DEA Scheduled Chemicals Found in Synthetic Cannabinoids
-
(Press Release)
NMS Labs Unveils ELISA Assay for Synthetic Cannabinoids in Urine
-
(Press Release)
NMS Labs Expands its Synthetic Cannabinoids Lab Tests in Urine to Keep Pace with Changes in Compounds Found in “Fake Pot”
-
(Press Release)
NMS Labs Offers Testing Aligned with Pennsylvania’s Legislation Banning Synthetic Drugs Found in “Bath Salts”
-
(Press Release)
Award-Winning Forensic Toxicologist Dan Isenschmid Joins NMS Labs
-
(Press Release)
NMS Labs Announces Its New Chromium and Cobalt Test to Assist the Medical Community with Post Market Surveillance Studies on Metal Implant Exposure Cases
-
(Press Release)
Latest blood test detects 12 popular synthetic cannabinoids in “fake pot”
-
(Press Release)
NMS Labs & Draeger Safety Diagnostics Inc. Announce Commitment to Join Forces in Delivering Total Oral Fluid Drug Testing Solution for Law Enforcement
-
(Press Release)
NMS Labs announces identification of metabolite of additional synthetic cannabinoid, JWH-250
-
(Press Release)
NMS Labs Promotes Shelly H. Carolan to CMO and James G. Murphy to CFO--Two New Posts on its Executive Leadership Team
-
(Press Release)
NMS Labs & Cerilliant announce identification of major metabolite of the synthetic cannabinoid JWH-073
-
(Press Release)
NMS Labs Announces Identification of Major Metabolite of the Synthetic Cannabinoid JWH-018
-
(Press Release)
NMS Labs Dr. Barry Logan co-authors report that begins effort to assess drug impairment while driving
-
(Press Release)
NMS Labs Announces Its Highly Specific Methotrexate Lab Test, Helping Physicians to Improve Patient Care by Eliminating False Positive Results
-
(Press Release)
The Fredric Rieders Family Renaissance Foundation appoints Shelly H. Carolan, MBA to its Board of Directors
-
(Press Release)
NMS Labs Becomes One of the First American Laboratories to Earn the Prestigious ISO 15189 Accreditation from the College of American Pathologists
-
(Press Release)
The Fredric Rieders Family Renaissance Foundation Names New Director – Dr. Barry K. Logan Brings His World-Renowned Toxicological Expertise in Forensic Science Education and Detection of Drug Impaired Driving to the Organization
-
(Press Release)
Michael F. Rieders, PhD, Newly Appointed to Board of the National Association of Medical Examiners (The NAME) Foundation
-
(Press Release)
NMS Labs Identifies New Synthetic Marijuana in “Legal Everywhere” Incense Products K3 and K4
-
(Press Release)
NMS Labs Now Performs Urine Tests for Metabolites of Synthetic Cannabinoids Found in K2 and Spice
-
(Press Release)
Process improvement business leader Marlow Hicks newly appointed as Vice President of Operations at NMS Labs
-
(Press Release)
NMS Labs receives ISO 17025 via ASCLD/LAB-International accreditation
-
(Press Release)
Phthalate Metabolites Developed and Offered at NMS Labs as a Follow Up to Its Groundbreaking Bisphenol-A Urine Test
-
(Press Release)
NMS Labs launches pain management lab test for Milnacipran, a new drug approved by the FDA for the treatment of Fibromyalgia pain
-
(Press Release)
NMS Labs Responds to National Health Concerns with Its Groundbreaking Test to Monitor Bisphenol-A (BPA) Levels in Humans
-
(Press Release)
NMS Labs Suspends An Across-The-Board Price Increase Of Its Forensic Testing In An Effort To Assist With Public Budget Deficit Issues
-
(Press Release)
NMS Labs Stands Up to Skyrocketing Healthcare Costs, Suspending Annual Across-the-Board Price Increase in 2010 for Esoteric Lab Tests
-
(Press Release)
NMS Labs Offers Law Enforcement Officials a Powerful Tool to Assist with Enforcing the Ban Of Salvinorin A & B